Novo Nordisk | Der Umsatz



Sales Veränderung Datum
ANI Pharmaceuticals USD 211.37M 14.27M 2025-06
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.53B 270M 2025-06
Bristol-Myers Squibb USD 12.27B 1.07B 2025-06
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 194.4M 37.2M 2025-06
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 15.56B 2.83B 2025-06
GlaxoSmithKline GBP 7.99B 470M 2025-06
Merck USD 15.81B 280M 2025-06
Novartis USD 14.05B 821M 2025-06
Novo Nordisk 76.86B 1.23B 2025-06
Novo Nordisk DKK 154.94B 76.85B 2025-06
Pacira USD 181.1M 12.18M 2025-06
Perrigo USD 1.06B 20M 2025-06
Prestige Brands USD 249.53M 46.99M 2025-06
Sanofi EUR 9.99B 90M 2025-06
Supernus Pharmaceuticals USD 165.5M 15.7M 2025-06
Zoetis USD 2.46B 240M 2025-06


Novo Nordisk Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.